`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`ACTAVIS, INC., ACTAVIS LABORATORIES FL, INC., ACTAVIS PHARMA,
`INC., AMNEAL PHARMACEUTICALS, LLC, AMNEAL
`PHARMACEUTICALS OF NEW YORK, LLC, AUROBINDO PHARMA LTD.,
`AUROBINDO PHARMA USA, INC., BRECKENRIDGE PHARMACEUTICAL,
`INC., VENNOOT PHARMACEUTICALS, LLC, SANDOZ INC., SUN
`PHARMA GLOBAL FZE, AND SUN PHARMACEUTICAL INDUSTRIES,
`LTD.,
`Petitioners,
`
`v.
`
`RESEARCH CORPORATION TECHNOLOGIES, INC.,
`Patent Owner.
`
`Case No. IPR2014-01126
`Patent No. RE 38,551
`
`PATENT OWNER RESEARCH CORPORATION TECHNOLOGIES,
`INC.’S MANDATORY NOTICES UNDER 37 C.F.R. § 42.8
`
`1
`
`
`
`
`
`
`
`
`
`
`
`
`
`Patent No. RE 38,551
`
`
`
`Case No. IPR2014-01126
`
`
`
`Pursuant to 37 C.F.R. § 42.8, Patent Owner Research Corporation
`
`Technologies, Inc. submits the following Mandatory Notices. In accordance with
`
`37 C.F.R. 42.8(a)(2), these Mandatory Notices are being timely filed within 21
`
`days of service of the petition.
`
`A. Real Party-In-Interest Under 37 C.F.R. § 42.8(b)(1)
`
`The real parties-in-interest are Research Corporation Technologies, Inc.;
`
`Harris FRC Corporation; UCB, Inc.; UCB Biopharma SPRL; and UCB Pharma
`
`GmbH.
`
`B. Related Matters Under 37 C.F.R. § 42.8(b)(2)
`
`Patent Owner identifies the following related judicial proceedings involving
`
`RE38,551 (“the ‘551 Patent”):
`
`Case Caption
`UCB, Inc. et al. v. Teva Pharmaceuticals USA Inc.
`et al., 1:13-cv-01148-LPS (D. Del.)
`UCB, Inc. et al. v. Accord Healthcare Inc. et al.,
`1:13-cv-01206-LPS (D. Del.)
`UCB, Inc. et al. v. Alembic Pharmaceuticals Ltd.
`et al., 1:13-cv-01207-LPS (D. Del.)
`UCB, Inc. et al. v. Amneal Pharmaceuticals LLC
`et al., 1:13-cv-01208-LPS (D. Del.)
`UCB, Inc. et al. v. Apotex Corp. et al., 1:13-cv-
`01209-LPS (D. Del.)
`UCB, Inc. et al. v. Aurobindo Pharma Ltd., et al.,
`1:13-cv-01210-LPS (D. Del.)
`UCB, Inc. et al. v. Breckenridge Pharmaceutical
`Inc. et al., 1:13-cv-01211-LPS (D. Del.)
`UCB, Inc. et al. v. Glenmark Generics Inc. USA et
`al., 1:13-cv-01212-LPS (D. Del.)
`
`
`
`2
`
`Disposition
`closed
`
`pending
`
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`closed
`
`
`
`Patent No. RE 38,551
`
`
`
`Case No. IPR2014-01126
`
`
`
`Case Caption
`UCB, Inc. et al. v. Hetero USA Inc. et al., 1:13-cv-
`01213-LPS (D. Del.)
`UCB, Inc. et al. v. Mylan Pharmaceuticals Inc. et
`al., 1:13-cv-01214-LPS (D. Del.)
`UCB, Inc. et al. v. Ranbaxy Laboratories Ltd. et
`al., 1:13-cv-01215-LPS (D. Del.)
`UCB, Inc. et al. v. Sandoz Inc., 1:13-cv-01216-
`LPS (D. Del.)
`UCB, Inc. et al. v ScieGen Pharmaceuticals Inc. et
`al., 1:13-cv-01217-LPS (D. Del.)
`UCB, Inc. et al. v Sun Pharma Global FZE et al.,
`1:13-cv-01218-LPS (D. Del.)
`UCB, Inc. et al. v. Watson Laboratories Inc. -
`Florida et al., 1:13-cv-01219-LPS (D. Del.)
`UCB, Inc. et al. v. Zydus Pharmaceuticals (USA)
`Inc. et al., 1:13-cv-01220-LPS (D. Del.)
`UCB, Inc. et al. v. Apotex Corp. et al., 1:14-cv-
`00834-LPS (D. Del.)
`UCB, Inc. et al. v. Sun Pharma Global FZE et al.,
`1:13-cv-05514 (N.D. Ill.)
`UCB, Inc. et al., v. Zydus Pharmaceuticals (USA),
`Inc. et al., 3:13-cv-04021 (D.N.J.)
`
`
`Disposition
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`closed
`
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`pending, consolidated with
`1:13-cv-01206-LPS (D. Del.)
`closed
`
`closed
`
`
`
`3
`
`
`
`Patent No. RE 38,551
`
`
`
`Case No. IPR2014-01126
`
`
`
`C. Lead and Back-Up Counsel Under 37 C.F.R. § 42.8(b)(3)
`
`Back-Up Counsel
`Enrique D. Longton (Reg. No. 47,304)
`rlongton@cov.com
`Postal and Hand-Delivery Address:
`Covington & Burling LLP
`1201 Pennsylvania Ave, NW
`Washington, DC 20004
`Telephone: (202) 662-5108
`Facsimile: (202) 778-5108
`
`
`
`
`Lead Counsel
`Andrea G. Reister (Reg. No. 36,253)
`areister@cov.com
`Postal and Hand-Delivery Address:
`Covington & Burling LLP
`1201 Pennsylvania Ave, NW
`Washington, DC 20004
`Telephone: (202) 662-5141
`Facsimile: (202) 778-5141
`Additional Back-Up Counsel
`Gregory S. Discher (Reg. No. 42,488)
`gdischer@cov.com
`Postal and Hand-Delivery Address:
`Covington & Burling LLP
`1201 Pennsylvania Ave, NW
`Washington, DC 20004
`Telephone: (202) 662- 5485
`Facsimile: (202) 778- 5485
`
`
`D.
`
`Service Information Under 37 C.F.R. § 42.8(b)(4)
`
`Service information for lead and back-up counsel is provided in the
`
`designation of lead and back-up counsel, above. Service of any documents via
`
`hand-delivery may be made at the postal mailing address of the respective lead and
`
`back-up counsel designated above.
`
`E.
`
`Power of Attorney
`
`A Power of Attorney to transact all business in the United States Patent &
`
`Trademark Office (“USPTO”) in connection with the above-referenced Inter
`
`Partes Review from Patent Owner Research Corporation Technologies, Inc. to the
`
`
`
`4
`
`
`
`L'i};:tt‘tz;%3'1‘:
`
`'L‘~»§-4;».
`
`,Ҥ{i:?i
`
`E,
`
`ifff121:<;<;:Tr’\J#;':. §t3'}f<Z,1?{)‘Mv»-{3§1Z2.f>
`
`£L°1.[b(>’%»’€3w£i*.i?f3ig;¥}éi'fi€t(1
`
`€;3(’31.'!I"1:£.t*J at (.To‘vi11ggtc3:1 «Sic 0IEi¥u'r2ing M0,? is being filed <;0’ntcu1*re:"zt1y
`
`with i;§izc‘¢:<~;€::
`
`.Me1.:’:dtat::;):'jy Nmttims.
`
`'i‘:’0'W’¢f.‘.1T‘ <.)fAttt<;)1*m':y'
`
`act:0m;'3ax1icd by at
`
`E§tzatc:2m:”:i §;?;n.t§e:r 3?’ f;,‘[,1?f?L[R,,
`
`§% :~3.73(M’b},
`
`::~.x<:%c:utteci by the‘ Patent Ownma
`
`R..:3S§3(3£31‘fL1§.Ey gubmittc-ad,
`
`
` Anifica C}. Reister
`
`Registration N()1/.?>6,.253
`E.?,mfiquc D. Longton
`Reg;i.st1‘at:ion No. 47,304
`€;‘tOV01.NCj}”[’(')N & BURI.,ING I...LP
`
`1201 Pennsylvania Avenue, NW"
`Washington, ‘DC 20004-2401
`(202) 662-6000
`Att(>1'.neys for Patent Owner
`
`
`
`if§If{51.l{”.l"‘[II¥“[(';‘.ATE? OF SVFZ.ilLV'.l.§;j§_
`
`.{’V:.11“:::1.1:.m!: hit: 137 (7i.1’*;Ii{.
`
`42.63, I l’1c::rs:rby «:.;:1"tiMt‘:y 1.11.511 cm this»; 3%’.)t;h. day cyfluly 20 3.4,
`
`f£E:2*;fc:ag;cv'iz%z;g: E{3‘z;;te::aii
`
`€;I}‘wa':<:=:r
`
`E%:.a;;t:.~;::asf<_=EMi:
`
`€,T:;*»z:j;‘°;<:.::i':::’i§gm "§"‘s2%.22Eméfizisgggémés, Erz<.;t."‘5~;:
`
`';‘s/£2sa“;.d2a,’z,s>;:’;v'
`
`T.‘~%}m:§x;*<-2:; UfiCi<i*3.“‘ 1%’? (i7:,I‘{E~l.
`
`was
`
`wags .*;::%1"'v::*::i, by Fw::ci‘E}5i:s<, as
`
`:*1.‘1<:2vaim:»; at Rams:
`
`as fzxst zmd 1‘*::‘1ia‘i.bi(: as EXP I391}?-ZSS :M/.Afl..J{:RDn on the fOH()Wii1§5 counsesi ofrecorci for
`
`Apa1;itic»1%1::%:'.
`
`Saxmlel 82- Park. ( spa.1*k@wins‘ton.com)
`Winsston & Strawn i_,jLI*’
`
`35 W. "Washer Drive
`
`(;‘hicagc) 1.1;, 6()6()i1
`
`.Andrew R. Somzfner (as0m1ne1‘@,w'i11st011.<.:om)
`Winston & Smwvn 1'..,LP
`
`1700 K Stmet, NW
`’Washing10rx DC 20006
`
` Date: July 30, 2014
`
`. ndr
`
`5K»...